INTRODUCTION {#s1}
============

Gastric cancer (GC) is the fifth most common malignancy worldwide and the third leading cause of cancer deaths \[[@R1]-[@R3]\]. Despite the improvements in diagnosis and treatment, the 5-year overall survival (OS) rate for advanced GC is still below 30% \[[@R4]-[@R5]\]. Age has been recognized as an important predictor of prognosis in many cancers \[[@R6]-[@R7]\]. The prevalence of GC increases with age, and the peak incidence is in old population of 60-70 years \[[@R8]-[@R9]\]. Clarification of the relationship between age and GC survival could reveal the impact of age on cancer prognosis and improve treatment efficacy \[[@R10]\]. Some studies reported that young GC patients usually had advanced stage and undifferentiated tumors \[[@R11]-[@R12]\]. Song *et al.* \[[@R8]\] argued that the prognosis of GC varied with age, and young patients had a higher survival rate after surgery compared to elderly patients. Similar results were also found in Li\'s study \[[@R6]\], where young patients with colorectal cancer after surgery had a higher cancer specific survival (CSS) rate than elderly ones \[[@R6]\]. Although the survival and age at diagnosis in GC has been investigated \[[@R8]-[@R9], [@R13]\], age-specific impact on the survival in GC patients with distant metastasis (M1) is still unclear. In this study, we compared the pathological characteristics and prognostic outcomes of GC with M1 in young patients with elderly ones based on Surveillance, Epidemiology, and End Results (SEER) population-based data.

RESULTS {#s2}
=======

Patient characteristics {#s2_1}
-----------------------

We identified 11, 299 GC patients with M1 diagnosed between 2004 and 2013 of the known age (≥18). In this study, we classified the patients into two groups: young (≤60) and elderly (\>60) patients, including 7,128 (63.09%) males and 4,171 (36.91%) females. The average follow-up period was 5 months. Patient demographics and pathological features were summarized in Table [1](#T1){ref-type="table"}.

###### Characteristics of GC patients with M1 from SEER database

  Characteristic                            Total (n)   Young (≤60)   Elderly (\>60)   X^2^       P value
  ----------------------------------------- ----------- ------------- ---------------- ---------- ---------
  Media follow up (month)                   5           6             4                           
  Years of diagnosis                                                                   0.003      0.955
   2004-2008                                5549        2456(49.1)    3093(49.1)                  
   2009-2013                                5750        2548(50.9)    3202(50.9)                  
  Sex                                                                                  2.953      0.086
   Male                                     7128        3113(62.2)    4015(63.8)                  
   Female                                   4171        1891(37.8)    2280(36.2)                  
  Race                                                                                 12.056     0.007
   White                                    8305        3617(72.3)    4688(74.5)                  
   Black                                    1434        664(13.3)     770(12.2)                   
   American Indian/Alaska Native            117         66(1.3)       51(0.8)                     
   Asian or Pacific Islander                1443        657(13.1)     786(12.5)                   
  Primary site                                                                         25.720     0.001
   Cardia, NOS                              3552        1520(30.4)    2032(32.3)                  
   Fundus of stomach                        463         197(3.9)      266(4.2)                    
   Body of stomach                          1021        470(9.4)      551(8.8)                    
   Gastric antrum                           1708        739(14.8)     969(15.4)                   
   Pylorus                                  233         85(1.7)       148(2.4)                    
   Lesser curvature of stomach NOS          642         269(5.4)      373(5.9)                    
   Greater curvature of stomach NOS         380         190(3.8)      190(3.0)                    
   Overlapping lesion of stomach            1061        508(10.2)     553(8.8)                    
   Stomach, NOS                             2239        1026(20.5)    1213(19.3)                  
  Grade                                                                                107.261    0.000
   Well/Moderately differentiated           1929        668(13.3)     1261(20.0)                  
   Poorly differentiated/Undifferentiated   6933        3301(66.0)    3632(57.7)                  
   Unknown                                  2437        1035(20.7)    1042(22.3)                  
  Histologic type                                                                      341.140    0.000
   Adenocarcinoma, NOS                      7338        2813(56.2)    4525(71.9)                  
   Carcinoma                                951         441(8.8)      510(8.1)                    
   Signet ring cell carcinoma               3010        1750(35.0)    1260(20.0)                  
  Surgery                                                                              13.492     0.000
   Yes                                      1693        819(16.4)     874(13.9)                   
   No                                       9606        4185(83.6)    5421(86.1)                  
  Marital status                                                                       1235.527   0.000
   Married                                  6649        2944(58.8)    3705(58.9)                  
   Divorced                                 978         455(9.1)      523(8.3)                    
   Widowed                                  1308        90(1.8)       1218(19.3)                  
   Single/separated/unmarried               1927        1336(26.7)    591(9.4)                    
   Unknown                                  437         179(3.6)      258(4.1)                    
  T stage                                                                              44.531     0.000
   T1                                       1814        730(14.6)     1084(17.2)                  
   T2                                       1784        809(16.2)     975(15.5)                   
   T3                                       1010        492(9.8)      518(8.2)                    
   T4                                       2316        1123(22.4)    1193(19.0)                  
   T~X~                                     4375        1850(37.0)    2525(40.1)                  

Characteristics of GC patients {#s2_2}
------------------------------

There were significant differences between the two groups in terms of race, primary site, grade, histologic type, surgery, marital status and clinical T stage (P\<0.05). Compared to elderly ones, young GC patients with M1 had more undifferentiated grade (66.0% VS 57.7%, P\<0.05), more signet-ring cancer (35.0% VS 20%, P\<0.05), and more stage T3 and T4 (9.8% VS 8.2%, 22.4% VS 19.0%; P\<0.05). Except for married patients in young and elderly groups (58.8% and 58.9%), most of young ones were single/separated/unmarried (26.7%), while most of elderly were widowed (19.3%). As shown in Table [1](#T1){ref-type="table"}, no significant differences were found between two groups in years of diagnosis (P=0.955) and sex (P=0.086).

Impact of age on GC survival outcomes {#s2_3}
-------------------------------------

As shown in Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"} and Figure [2](#F2){ref-type="fig"}, the 1- and 3-year CCS rates of GC were 29.0% and 6.2% in young group, and 22.8% and 4.8% in elderly group, which had significant difference using univariate (X^2^=116.430, P\<0.001) and multivariate analysis (young group as ref., HR=0.808, 95%CI: 0.773∼0.844, P\<0.001). Year of diagnosis, sex, race, primary site, grade, histological type, surgery, marital status and clinical T stage were identified as significant risk factors for poor survival by univariate analysis (Table [2](#T2){ref-type="table"} and Figure [1](#F1){ref-type="fig"}, P\<0.05). Female, black and American Indian/Alaska Native and widowed GC patients also had shorter survival periods (Table [2](#T2){ref-type="table"} and Figure [1](#F1){ref-type="fig"}). As shown in Table [2](#T2){ref-type="table"}, the 1- and 3-year CCS rates of patients in stage T1 (25.3% and 5.1%) were lower than that of in T2 (35.2% and 8.4%) and T3 (34.7% and 8.8%), but higher than that in T4 (22.8% and 4.9%) and Tx (21.0% and 3.8%). Multivariate analysis with Cox regression revealed that year of diagnosis, age, race, primary site, grade, histological type, surgery, marital status and pathological T stage were independent prognostic factors (Table [3](#T3){ref-type="table"}, P\<0.05).

###### Univariate survival analyses of GC patients with M1

  Variable                                  Total (n)   1-year CSS   3-year CSS   Log rank x^2^   P value
  ----------------------------------------- ----------- ------------ ------------ --------------- ---------
  Years of diagnosis                                                              18.913          0.000
   2004-2008                                5549        24%          4.8%                         
   2009-2013                                5750        27.2%        6.3%                         
  Sex                                                                             5.845           0.016
   Male                                     7128        26.3%        5.7%                         
   Female                                   4171        24.3%        4.9%                         
  Age                                                                             116.430         0.000
   Young                                    5004        29.0%        6.2%                         
   Elderly                                  6295        22.8%        4.8%                         
  Race                                                                            19.193          0.000
   White                                    8305        25.3%        5.2%                         
   Black                                    1434        23.1%        4.8%                         
   American Indian/Alaska Native            117         23.2%        4.8%                         
   Asian or Pacific Islander                1443        29.8%        7.2%                         
  Primary site                                                                    162.320         0.000
   Cardia, NOS                              3552        29.2%        6.5%                         
   Fundus of stomach                        463         24.6%        4.8%                         
   Body of stomach                          1021        25.5%        4.8%                         
   Gastric antrum                           1708        27.4%        6.9%                         
   Pylorus                                  233         25.7%        6.4%                         
   Lesser curvature of stomach NOS          642         30.3%        7.0%                         
   Greater curvature of stomach NOS         380         26.0%        4.8%                         
   Overlapping lesion of stomach            1061        21.2%        4.1%                         
   Stomach, NOS                             2239        18.9%        3.1%                         
  Grade                                                                           66.031          0.000
   Well/Moderately differentiated           1929        32.3%        7.9%                         
   Poorly differentiated/Undifferentiated   6933        24.9%        4.9%                         
   Unknown                                  2437        22.0%        4.9%                         
  Histologic type                                                                 11.442          0.003
   Adenocarcinoma, NOS                      7338        26.5%        6.0%                         
   Carcinoma                                951         23.4%        5.1%                         
   Signet ring cell carcinoma               3010        23.8%        4.1%                         
  Surgery                                                                         313.299         0.000
   Yes                                      1693        41.6%        11.7%                        
   No                                       9606        22.6%        4.2%                         
  Marital status                                                                  119.561         0.000
   Married                                  6649        27.1%        5.9%                         
   Divorced                                 978         25.3%        3.3%                         
   Widowed                                  1308        17.7%        3.3%                         
   Single/separated/unmarried)              1927        24.4%        5.8%                         
   Unknown                                  437         30.3%        7.0%                         
  T stage                                                                         252.356         0.000
   T1                                       1814        25.3%        5.1%                         
   T2                                       1784        35.2%        8.4%                         
   T3                                       1010        34.7%        8.8%                         
   T4                                       2316        22.8%        4.9%                         
   T~X~                                     4375        21.0%        3.8%                         

###### Multivariate Cox model analyses of prognostic factors of GC patients with M1

  Variable                                  HR      95%CI           P value
  ----------------------------------------- ------- --------------- ---------
  Years of diagnosis                                                0.000
   2004-2008                                        Ref             
   2009-2013                                1.115   (1.070∼1.161)   0.000
  Sex                                                               0.900
   Male                                             Ref             
   Female                                   1.035   (0.989∼1.082)   0.136
  Age                                                               0.000
   Young                                            Ref             
   Elderly                                  0.808   (0.773∼0.844)   0.000
  Race                                                              0.008
   White                                            Ref             
   Black                                    1.104   (1.037∼1.175)   0.002
   American Indian/Alaska Native            1.139   (1.050∼1.235)   0.002
   Asian or Pacific Islander                1.281   (1.045∼1.570)   0.017
  Primary site                                                      0.000
   Cardia, NOS                                      Ref             
   Fundus of stomach                        0.754   (0.709∼0.801)   0.000
   Body of stomach                          0.838   (0.751∼0.935)   0.002
   Gastric antrum                           0.842   (0.776∼0.913)   0.000
   Pylorus                                  0.855   (0.798∼0.917)   0.000
   Lesser curvature of stomach NOS          0.918   (0.792∼1.062)   0.250
   Greater curvature of stomach NOS         0.750   (0.680∼0.828)   0.000
   Overlapping lesion of stomach            0.854   (0.758∼0.962)   0.009
   Stomach, NOS                             0.950   (0.877∼1.029)   0.207
  Grade                                                             0.001
   Well/Moderately differentiated                   Ref             
   Poorly differentiated/Undifferentiated   0.880   (0.822∼0.943)   0.000
   Unknown                                  1.044   (0.991∼1.099)   0.103
  Histologic type                                                   0.003
   Adenocarcinoma, NOS                              Ref             
   Carcinoma                                0.945   (0.899∼0.995)   0.30
   Signet ring cell carcinoma               1.003   (0.926∼1.086)   0.946
  Surgery                                                           0.000
   Yes                                              Ref             
   No                                       0.638   (0.597∼0.681)   0.000
  Marital status                                                    0.000
   Married                                          Ref             
   Divorced                                 1.076   (0.963∼1.201)   0.196
   Widowed                                  1.234   (1.087∼1.401)   0.001
   Single/separated/unmarried)              1.371   (1.211∼1.552)   0.000
   Unknown                                  1.194   (1.061∼1.344)   0.003
  T stage                                                           0.000
   T1                                               Ref             
   T2                                       0.922   (0.868∼0.979)   0.008
   T3                                       0.790   (0.740∼0.842)   0.000
   T4                                       0.852   (0.785∼0.942)   0.000
   T~X~                                     0.999   (0.944∼1.056)   0.962

![Survival curves in GC patients with M1 of different primary site, surgical treatment, marital status and T stage\
**(A)** Primary site. X^2^ = 162.320, P\<0.001; **(B)** Surgery. X^2^ = 313.299, P\<0.001; **(C)** Marital status. X^2^ = 119.561, P\<0.001; **(D)** T stage. X^2^ =252.356, P\<0.001.](oncotarget-08-97090-g001){#F1}

![Survival curves in GC patients with M1 of different age\
**(A)** All patients. Young group vs. Elderly group, X^2^ = 116.430, P\<0.001; **(B)** T1 stage. Young group vs. Elderly group, X^2^= 9.817, P=0.002; **(C)** T2 stage. Young group vs. Elderly group, X^2^ = 20.034, P\<0.001; **(D)** T3 stage. Young group vs. Elderly group, X^2^ = 8.278, P=0.004; **(E)** T4 stage. Young group vs. Elderly group, X^2^ = 22.753, P\<0.001; **(F)** Tx stage. Young group vs. Elderly group, X^2^ = 51.779, P\<0.001.](oncotarget-08-97090-g002){#F2}

Stratified analysis of age on GC survival based on T stage {#s2_4}
----------------------------------------------------------

We then further analyzed the effect of age on 1- and 3-year CSS at each clinical T stage. We found that young patients had significantly better 1- and 3-year CSS than elderly patients in each T stage (Table [4](#T4){ref-type="table"}, P\<0.05). Age was further validated as an independent survival factor in multivariate Cox regression at T1 stage (elderly, HR: 0.824, 95%CI: 0.742∼0.915; P\<0.001), T2 stage (elderly, HR: 0.756, 95%CI: 0.680∼0.841; P\<0.001), T3 stage (elderly, HR: 0.818, 95%CI: 0.713∼0.938; P=0.004), T4 stage (elderly, HR: 0.811, 95%CI: 0.742∼0.886; P\<0.001) and Tx stage (elderly, HR: 0.784, 95%CI: 0.733∼0.838; P\<0.001) patients (Table [4](#T4){ref-type="table"}).

###### Univariate and multivariate analysis of age on CSS of different T stages

  Variable   Total (n)   1-year CSS   3-year CSS   Univariate analysis   Multivariate analysis                        
  ---------- ----------- ------------ ------------ --------------------- ----------------------- -------------------- ---------
                                                   Log rank x^2^         P value                 HR (95%CI)           P value
  **T1**     1814                                  9.817                 0.002                                        
  Age                                                                                                                 
   Young     730         28.7%        5.2%                                                       Ref                  
   Elderly   1084        23.0%        5.0%                                                       0.824(0.742∼0.915)   0.000
  **T2**     1784                                  20.034                0.000                                        
  Age                                                                                                                 
   Young     809         39.6%        9.4%                                                       Ref                  
   Elderly   975         31.5%        7.5%                                                       0.756(0.680∼0.841)   0.000
  **T3**     1010                                  8.278                 0.004                                        
  Age                                                                                                                 
   Young     492         38.8%        10.1%                                                      Ref                  
   Elderly   518         33.0%        7.5%                                                       0.818(0.713∼0.938)   0.004
  **T4**     2316                                  22.753                0.000                                        
  Age                                                                                                                 
   Young     1123        24.7%        5.9%                                                       Ref                  
   Elderly   1193        20.9%        3.9%                                                       0.811(0.742∼0.886)   0.000
  **Tx**     4375                                  51.779                0.000                                        
  Age                                                                                                                 
   Young     1850        24.5%        4.3%                                                       Ref                  
   Elderly   2525        18.5%        3.4%                                                       0.784(0.733∼0.838)   0.000

P values refer to comparison between two groups and were adjusted for years of diagnosis, sex, race, primary site, grade, histological type, surgery, marital status and clinical T stage.

DISCUSSION {#s3}
==========

Despite advancement of diagnosis and treatment of GC, the prognosis remains poor with a 5-year OS of less than 30% in most countries \[[@R4]-[@R5], [@R14]\]. In China, GC is the second leading cause of cancer death, and the current 5 year CSS is low because more than 80% of patients are diagnosed at an advanced stage \[[@R15]-[@R16]\]. Age is considered as one of the independent factors of several cancers \[[@R6]-[@R9], [@R12]\]. Investigation of important prognostic factors of GC development could further understand and improve the treatment of the advanced disease. We identified 11, 299 GC patients with M1 diagnosed between 2004 and 2013 with a known age based on SEER population-based data. The current definition of elderly patients remains controversial. Some studies used the cutoff age of 50 years, while others used 30 years or 45 years \[[@R6], [@R8]-[@R9], [@R17]\]. In this study, we divided GC patients into young (≤60) and elderly (\>60) groups according to recent publications and the new age subsection-standard of the United Nations world health organization \[[@R8]-[@R9]\].

Recently, some studies have investigated the prognostic outcome of GC in young patients in comparison to the elderly, but yielded inconclusive results \[[@R18]-[@R19]\]. It has been suggested that young patients suffered worse survival due to the characteristics of themselves and different tumor behavior \[[@R20]\]. Chen *et al.* \[[@R9]\] reported that between 56 and 65 years have more favorable clinicopathologic characteristics and better CSS than the other groups in operable gastric cancer patients. While Song *et al.* \[[@R8]\] argued that the prognosis of GC varied with age, and young patients suffered a higher survival rate after surgery compared to elderly patients. In our study, we found that young GC patients with M1 had a higher CCS rate compared to elderly ones. The 1- and 3-year CCS rates of GC were 29.0% and 6.2% in young group and 22.8% and 4.8% in elderly group, which had significant difference by univariate (X^2^=116.430, P\<0.001) and multivariate analysis (young group as ref., HR=0.808, 95%CI: 0.773∼0.844) (P\<0.001). It might be attributed to two main reasons. One could be explained by that the poor tolerance of extensive lymphadenectomy and standardized chemotherapy \[[@R21]-[@R22]\]. Clinicians are more likely to provide all remedial options for young patients since they have the better health condition and tolerance of chemotherapy \[[@R31]\]. The other reason was that young patients usually have better tolerance of surgery and better recovery \[[@R23]-[@R24]\]. Although some ones thought that oldness would another reason for affecting long-time survival, most of GC patients with distant metastasis died in 1 year and 3-year CSS was less than 10%.

Another interesting finding was that compared to elderly ones, young GC patients with M1 had characteristics of more poor or undifferentiated grade (66.0% VS 57.7%, P\<0.05), more signet-ring cancer (35.0% VS 20%, P\<0.05), more stage T3 and T4 (9.8% VS 8.2%, 22.4% VS 19.0%; P\<0.05). Li *et al.* \[[@R6]\] also found young patients presented higher proportions of unfavorable behavior as well as advanced stage disease. In contrast, it was noted that that young patients suffered worse survival due to the personal characteristics and different tumor behavior \[[@R20]\]. It is well known that mucinous, signet-ring and poorly differentiated tumors tend to have a poorer prognosis compared to well and moderately differentiated tumors \[[@R25]\]. It is thought that gastric cancer results from a combination of environmental factors and an accumulation of specific genetic alterations. The genetic information of young patients is different from that which leads to sporadic carcinomas at an older age. And there is a tendency of late diagnosis of the disease in young patients \[[@R26]-[@R27]\].

In addition, we found that except for married ones in young and elderly groups (58.8% and 58.9%), most of young GC patients were single/separated/unmarried (26.7%), while most of elderly were widowed (19.3%) who had the shortest survivals. Li *et al.* \[[@R28]\] selected 112, 776 colorectal cancer from SEER data and found unmarried patients were at greater risk of cancer specific mortality while widowed patients were at the highest risk of death than the other groups. Jin *et al.* \[[@R29]\] suggested that marriage had a protective effect against under-treatment and cause-specific mortality in GC. It might be attributed to that widowed patients lack of social and connubial support \[[@R30]\] and psychosocial distress \[[@R31]\]. Widowed cancer patients showed more distress, depression, and anxiety than married counterparts, which might be attributed to that spouse could share the emotional burden and provide appropriate his/her support \[[@R32]\]. Depression or/and nonadherence have been found to be directly correlated to widowed cancer individuals \[[@R33]\]. It was reported that depression was related to VEGF, stimulating endothelial cell migration, proliferation and proteolytic activity in cancers \[[@R34]\]. Depression was strongly influenced by poor adherence to medical treatment.

This study has several limitations. First, the SEER database does not include information of therapeutic options such as detailed information of chemotherapy, targeted therapy, immunotherapy, recurrence and metastasis, which may also impact patients' prognosis \[[@R35]\]. Second, the SEER database is lack of detailed description of the organ metastasis (liver, lung, bone or brain). Third, since most patients did not receive operation, we used clinical T stage instead of pathological T, which also may affect the analysis of prognosis in this study. Despite these limitations, we first reported that age was an independent prognostic factor in GC patients with M1. Further studies are needed to verify our findings.

MATERIALS AND METHODS {#s4}
=====================

Study population and data extracted {#s4_1}
-----------------------------------

The SEER database and SEER-stat software (SEER^\*^Stat 8.3.2) were used to search GC patients with M1 between 2004 and 2013 with a known age (≥18). Years of diagnosis, sex, race, primary site, grade, histological type, surgery, marital status, clinical T stage, and CSS were extracted from the SEER database. Histological types were limited to adenocarcinoma (8140/3), carcinoma (8010/3; 8020/3; 8021/3 and 8145/3) and signet ring cell carcinoma (8490/3). Survival time was calculated from the date of diagnosis to the date of cancer-specific death. The exclusion criterions included: age\<18, no evaluation of histological type, multiple malignant neoplasms, died within 30 days or information on CSS and survival months unavailable.

Statistical analysis {#s4_2}
--------------------

Baseline characteristics were compared using the X^2^ test for nominal variables. Survival curves were generated using Kaplan--Meier analyses, and the differences between the curves were analyzed by log-rank test. Cox regression models were built for analysis of risk factors for survival outcomes. Statistical analyses were performed using the statistical software package SPSS for Windows, version 19.0 (SPSS Inc., Chicago, IL, USA). All P values were two-sided. P\<0.05 was considered statistically significant.
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